For the quarter ending 2025-09-30, PRLD has $94,755K in assets. $36,221K in debts. $47,532K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 47,532 | 25,752 | ||
| Marketable securities | 7,425 | 47,464 | ||
| Prepaid expenses and other current assets | 3,373 | 3,660 | ||
| Total current assets | 58,330 | 76,876 | ||
| Restricted cash | 3,235 | 4,044 | ||
| Property and equipment, net | 5,531 | 5,956 | ||
| Operating lease right-of-use asset | 27,549 | 27,932 | ||
| Other assets | 110 | 110 | ||
| Total assets | 94,755 | 114,918 | ||
| Accounts payable | 2,533 | 4,962 | ||
| Accrued expenses and other current liabilities | 12,930 | 13,235 | ||
| Operating lease liability | 2,727 | 2,711 | ||
| Finance lease liability | 0 | 0 | ||
| Total current liabilities | 18,190 | 20,908 | ||
| Other liabilities | 2,904 | 2,966 | ||
| Operating lease liability | 15,127 | 15,206 | ||
| Total liabilities | 36,221 | 39,080 | ||
| Common stock-Voting Common Stock | 4 | 4 | ||
| Common stock-Nonvoting Common Stock | 1 | 1 | ||
| Additional paid-in capital | 725,131 | 722,713 | ||
| Accumulated other comprehensive income | 2 | -1 | ||
| Accumulated deficit | -666,604 | -646,879 | ||
| Total stockholders equity | 58,534 | 75,838 | ||
| Total liabilities and stockholders equity | 94,755 | 114,918 | ||
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD)